BLOCKADE OF COMPLEMENT ACTIVATION PREVENTS LOCAL AND PULMONARY ALBUMIN LEAK AFTER LOWER TORSO ISCHEMIA REPERFUSION

被引:109
作者
LINDSAY, TF
HILL, J
ORTIZ, F
RUDOLPH, A
VALERI, CR
HECHTMAN, HB
MOORE, FD
机构
[1] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT SURG,75 FRANCIS ST,BOSTON,MA 02115
[2] T CELL SCI INC,CAMBRIDGE,MA
[3] NAVAL BLOOD RES LABS,CHELSEA,MA
关键词
D O I
10.1097/00000658-199212000-00010
中图分类号
R61 [外科手术学];
学科分类号
摘要
Lower torso ischemia and reperfusion leads to both local and remote tissue injuries. The purpose of this study was to assess the role of complement in mediating the local and remote microvascular permeability after bilateral hind limb tourniquet ischemia. Four hours of ischemia and 4 hours of reperfusion produced an increased skeletal muscle permeability index (muscle/blood I-125 albumin ratio) of 2.90 +/- 0.35 compared with the index in nonischemic muscle of 0.25 +/- 0.02 (p < 0.01). Muscle wet-to-dry-weight ratio increased from 3.93 +/- 0.04 in sham to 5.55 +/- 0.09 in ischemic muscle (p < 0.0001). Lung permeability rose at 4 hours as indicated by the increased broncheoalveolar lavage (BAL)/blood I-125 albumin ratio 4.36 +/- 0.41 X 10(-3) versus sham 2.64 +/- 0.28 X 10(-3) (p < 0.05) and neutrophil sequestration 0.28 +/- 0.02 U/g myeloperoxidase (MPO) versus sham 0.14 +/- 0.02 U/g (p < 0.001). Serum lytic activity of the classical but not the alternate complement pathway was reduced. The soluble complement receptor (sCR1) was used to inhibit complement activity and attenuated the increase in the permeability index after reperfusion in ischemic muscle 1.11 +/- 0.08 (p < 0.01) and reduced the lung BAL/blood I-125 albumin ratio to sham levels 2.46 +/- 0.39 X 10(-3) (p < 0.05) at 6 mg/animal, without reducing the lung neutrophil sequestration, 0.24 +/- 0.02 U/g. The authors conclude that complement activation occurred during tourniquet ischemia and mediated permeability changes in the ischemic muscle and the lungs during reperfusion.
引用
收藏
页码:677 / 683
页数:7
相关论文
共 23 条
[1]   PRIMED NEUTROPHILS INJURE RAT LUNG THROUGH A PLATELET-ACTIVATING FACTOR-DEPENDENT MECHANISM [J].
ANDERSON, BO ;
POGGETTI, RS ;
SHANLEY, PF ;
BENSARD, DD ;
PITMAN, JM ;
NELSON, DW ;
WHITMAN, GJR ;
BANERJEE, A ;
HARKEN, AH .
JOURNAL OF SURGICAL RESEARCH, 1991, 50 (05) :510-514
[2]   PULMONARY LEUKOSEQUESTRATION INDUCED BY HINDLIMB ISCHEMIA [J].
ANNER, H ;
KAUFMAN, RP ;
KOBZIK, L ;
VALERI, CR ;
SHEPRO, D ;
HECHTMAN, HB .
ANNALS OF SURGERY, 1987, 206 (02) :162-167
[3]   THE ISCHEMIC LEG AS A SOURCE OF COMPLEMENT ACTIVATION [J].
BENGTSON, A ;
HOLMBERG, P ;
HEIDEMAN, M .
BRITISH JOURNAL OF SURGERY, 1987, 74 (08) :697-700
[4]   REGULATION OF THE AMPLIFICATION C-3 CONVERTASE OF HUMAN-COMPLEMENT BY AN INHIBITORY PROTEIN ISOLATED FROM HUMAN-ERYTHROCYTE MEMBRANE [J].
FEARON, DT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (11) :5867-5871
[5]   LUNG MYELOPEROXIDASE AS A MEASURE OF PULMONARY LEUKOSTASIS IN RABBITS [J].
GOLDBLUM, SE ;
WU, KM ;
JAY, M .
JOURNAL OF APPLIED PHYSIOLOGY, 1985, 59 (06) :1978-1985
[6]   COMPLEMENT ACTIVATION BY HOMOGENIZED MUSCLE-TISSUE [J].
HEIDEMAN, M ;
KAIJSER, B ;
GELIN, LE .
JOURNAL OF SURGICAL RESEARCH, 1978, 25 (06) :518-522
[7]  
HEIDEMAN M, 1988, ARCH SURG-CHICAGO, V123, P188
[8]  
HUGO F, 1990, CLIN EXP IMMUNOL, V81, P132
[9]   MOLECULAR-BASIS OF COMPLEMENT ACTIVATION IN ISCHEMIC MYOCARDIUM - IDENTIFICATION OF SPECIFIC MOLECULES OF MITOCHONDRIAL ORIGIN THAT BIND HUMAN C1Q AND FIX COMPLEMENT [J].
KAGIYAMA, A ;
SAVAGE, HE ;
MICHAEL, LH ;
HANSON, G ;
ENTMAN, ML ;
ROSSEN, RD .
CIRCULATION RESEARCH, 1989, 64 (03) :607-615
[10]   THROMBOXANE-A2 MEDIATES INCREASED PULMONARY MICROVASCULAR PERMEABILITY FOLLOWING LIMB ISCHEMIA [J].
KLAUSNER, JM ;
PATERSON, IS ;
GOLDMAN, G ;
KOBZIK, L ;
VALERI, CR ;
SHEPRO, D ;
HECHTMAN, HB .
CIRCULATION RESEARCH, 1989, 64 (06) :1178-1189